C21 Investments Inc. (CWLXF): Total Liabilities
$28.99M
As of 2026-03-31
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $28.99M | +2.3% | 2026-06-12, Balance as of period end |
| 2025-03-31 | $28.32M | +16.8% | 2026-06-12, Balance as of period end |
| 2024-03-31 | $24.25M | n/a | 2025-06-23, Balance as of period end |
| 2024-01-31 | $23.48M | -2.1% | 2025-06-23, Balance as of period end |
| 2023-01-31 | $24.00M | -14.7% | 2024-08-08, Balance as of period end |
| 2022-01-31 | $28.12M | -35.5% | 2023-07-28, Balance as of period end |
| 2021-01-31 | $43.56M | n/a | 2023-07-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| C21 Investments Inc. (CWLXF) | 2026-03-31 | $28.99M | +2.3% |
| Leef Brands Inc. (LEEEF) | 2025-12-31 | $44.67M | -19.4% |
| Synergy CHC Corp. (SNYRQ) | 2025-12-31 | $33.29M | +1.0% |
| Cyanotech Corp (CYAN) | 2025-03-31 | $14.61M | +9.8% |
| Charlie's Holdings, Inc. (CHUC) | 2025-12-31 | $8.14M | +42.2% |
| Bon Natural Life Ltd (BON) | 2025-09-30 | $27.19M | +56.1% |
| Fitlife Brands, Inc. (FTLF) | 2025-12-31 | $62.68M | +179.8% |
| Mannatech Inc (MTEX) | 2025-12-31 | $35.22M | +28.3% |
| Niagen Bioscience, Inc. (NAGE) | 2025-12-31 | $29.87M | +34.7% |
Compare CWLXF, LEEEF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗